David A Scheiblin

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Prostate Cancer

Top Venues

British journal of cancer

Journal of virology

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Melissa V Fernandez-de Céspedes, Huxley K Hoffman, Hannah Carter, Lacy M Simons, Lwar Naing, Sherimay D Ablan, David A Scheiblin, Judd F Hultquist, Schuyler B van Engelenburg, Eric O Freed
Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4 + T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines. Journal of virology (2022)
Anne C Gilmore, Sarah J Flaherty, Veena Somasundaram, David A Scheiblin, Stephen J Lockett, David A Wink, William F Heinz
An in vitro tumorigenesis model based on live-cell-generated oxygen and nutrient gradients. Communications biology 4 (1) (2021)
Hanna T Sjoberg, Yiannis Philippou, Anette L Magnussen, Iain D C Tullis, Esther Bridges, Andrea Chatrian, Joel Lefebvre, Ka Ho Tam, Emma A Murphy, Jens Rittscher, Dina Preise, Lilach Agemy, Tamar Yechezkel, Sean C Smart, Paul Kinchesh, Stuart Gilchrist, Danny P Allen, David A Scheiblin, Stephen J Lockett, David A Wink, Alastair D Lamb, Ian Geoffrey Mills, Adrian L Harris, Ruth J Muschel, Boris Vojnovic, Avigdor Scherz, Freddie C Hamdy, Richard John Bryant
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. British journal of cancer 125 (4) (2021)